Back to Search
JOHANNA SAID, D.O.
D.O.
Pediatric Emergency Medicine (Pediatrics) Physician
NPI: 1639596513IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pediatrics Physician
Pediatrics
Code: 208000000X
04085(KY)1016107(MA)58.005635(OH)
Pediatric Emergency Medicine (Pediatrics) PhysicianPrimary
Pediatrics — Pediatric Emergency Medicine
Code: 2080P0204X
1016107(MA)
CMS Specialties
PrimaryPEDIATRIC MEDICINE
Education
NOVA SOUTHEASTERN COLLEGE OF OSTEO MEDICINE
Class of 2014
Research & Publications (20)
Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis.
PMID 19060246·Blood·2009
7-preclinical
Molecular signatures of localized clear cell renal cell carcinoma to predict disease-free survival after nephrectomy.
PMID 19240241·Cancer Epidemiol Biomarkers Prev·2009
8-other
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.
PMID 19117935·Invest Ophthalmol Vis Sci·2009
8-other
Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.
PMID 19035457·Int J Cancer·2009
8-other
Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification.
PMID 19230920·J Urol·2009
8-other
Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
PMID 19124809·J Clin Oncol·2009
8-other
Cytogenetic and molecular tumor profiling for type 1 and type 2 papillary renal cell carcinoma.
PMID 19228721·Clin Cancer Res·2009
8-other
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
PMID 19605406·Cancer Res·2009
7-preclinical
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo.
PMID 18627377·Cancer Sci·2008
7-preclinical
Targeted deletion of hepatic Igf1 in TRAMP mice leads to dramatic alterations in the circulating insulin-like growth factor axis but does not reduce tumor progression.
PMID 18451161·Cancer Res·2008
7-preclinical
Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies.
PMID 18823034·Cancer·2008
8-other
Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma.
PMID 18464292·Int J Cancer·2008
8-other
The prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian antenatal population.
PMID 19133039·Aust N Z J Obstet Gynaecol·2008
8-other
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
PMID 19021050·Leuk Lymphoma·2008
3-trial
High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - a CALGB 59804 correlative study.
PMID 18452103·Leuk Lymphoma·2008
8-other
Functional domains of CCN1 (Cyr61) regulate breast cancer progression.
PMID 18575751·Int J Oncol·2008
8-other
Induction of sodium iodide symporter gene and molecular characterisation of HNF3 beta/FoxA2, TTF-1 and C/EBP beta in thyroid carcinoma cells.
PMID 18682709·Br J Cancer·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 231 E CHESTNUT ST
LOUISVILLE, KY 40202 - Phone
- (502) 629-6000
Quick Facts
- NPI
- 1639596513
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 12
- Publications
- 20
Are you this provider?
Claim Your Profile